These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6223765)

  • 21. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
    Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH
    Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic and proliferative responses of human thoracic duct lymphocytes: effect of thoracic duct drainage in uremic patients.
    Cordier G; Brochier J; Revillard JP
    Clin Immunol Immunopathol; 1976 May; 5(3):351-9. PubMed ID: 1277591
    [No Abstract]   [Full Text] [Related]  

  • 24. Derangement of humoral immune system in nondialyzed uremic patients.
    Kamata K; Okubo M
    Jpn J Med; 1984 Feb; 23(1):9-15. PubMed ID: 6379244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of suppressor cell activity by cyclosporin A and/or uremic serum in normal versus uremic peripheral blood mononuclear cells.
    Modai D; Berman S; Cohen D; Amit M; Cohn M; Weissgarten J; Averbukh Z
    Int Arch Allergy Appl Immunol; 1990; 91(3):291-6. PubMed ID: 2141326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor cells assayed by numerical and functional tests in chronic renal failure.
    Lortan JE; Kiepiela P; Coovadia HM; Seedat YK
    Kidney Int; 1982 Aug; 22(2):192-7. PubMed ID: 6290745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)].
    Reis HE; Cremer W; Heimsoth VH; Graffe-Achelis C; Wetter O
    Klin Wochenschr; 1975 May; 53(10):467-72. PubMed ID: 1195651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.
    Dumann H; Meuer SC; Köhler H
    Nephron; 1990; 56(2):162-5. PubMed ID: 2243571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T lymphocyte subsets in chronic uremic patients treated with maintenance hemodialysis.
    Morra L; Ponassi GA; Gurreri G; Moccia F; Mela GS; Bessone G
    Biomed Pharmacother; 1990; 44(1):53-6. PubMed ID: 1369694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response in experimentally induced uremia. III. Uremic adherent spleen cells are defective in their ability to act as stimulators in mixed-leukocyte culture.
    Alevy YG; Slavin RG
    Clin Immunol Immunopathol; 1982 Aug; 24(2):227-38. PubMed ID: 6214355
    [No Abstract]   [Full Text] [Related]  

  • 31. Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy.
    Lin CY; Huang TP
    Am J Nephrol; 1988; 8(5):355-62. PubMed ID: 2977061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.
    Deem RL; Targan SR; Niederlehner A; Shanahan F
    Clin Exp Immunol; 1990 Jun; 80(3):387-94. PubMed ID: 1695560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia.
    Mezzano S; Pesce AJ; Pollak VE; Michael JG
    Nephron; 1984; 36(1):15-9. PubMed ID: 6606788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective radioresistant suppressor cell activity in hemodialysis patients.
    Mirapeix E; Montoliu J; Suárez C; López Pedret J; Revert L
    Nephron; 1985; 41(2):184-8. PubMed ID: 2931611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells.
    McIrvine AJ; O'Mahony JB; Saporoschetz I; Mannick JA
    Ann Surg; 1982 Sep; 196(3):297-304. PubMed ID: 6214221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered monocyte function in uremia.
    Gibbons RA; Martinez OM; Garovoy MR
    Clin Immunol Immunopathol; 1990 Jul; 56(1):66-80. PubMed ID: 2192826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterization of immunological responsiveness of uremic patients.
    Kunori T; Fehrman I; Ringdén O; Möller E
    Nephron; 1980; 26(5):234-9. PubMed ID: 6448353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of adoptive transfer of tuberculin sensitivity in acute uremia.
    Johnston MF; Slavin RG
    J Lab Clin Med; 1976 Mar; 87(3):457-61. PubMed ID: 1082465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.